June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Differential expression of DNA repair genes in prognostically-good and bad Uveal Melanoma
Author Affiliations & Notes
  • Mehmet Dogrusoz
    Ophthalmology, LUMC, The Hague, Netherlands
  • Andrea Ruschel Trasel
    Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
  • Sake I. van Pelt
    Ophthalmology, LUMC, The Hague, Netherlands
  • Sjoerd G. van Duinen
    Pathology, LUMC, Leiden, Netherlands
  • Pieter A. van der Velden
    Ophthalmology, LUMC, The Hague, Netherlands
  • Gregorius P M Luyten
    Ophthalmology, LUMC, The Hague, Netherlands
  • Martine J Jager
    Ophthalmology, LUMC, The Hague, Netherlands
  • Footnotes
    Commercial Relationships   Mehmet Dogrusoz, None; Andrea Ruschel Trasel, None; Sake van Pelt, None; Sjoerd van Duinen, None; Pieter van der Velden, None; Gregorius Luyten, None; Martine Jager, None
  • Footnotes
    Support  Horizon 2020 UM CURE grant #667787
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3963. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Mehmet Dogrusoz, Andrea Ruschel Trasel, Sake I. van Pelt, Sjoerd G. van Duinen, Pieter A. van der Velden, Gregorius P M Luyten, Martine J Jager; Differential expression of DNA repair genes in prognostically-good and bad Uveal Melanoma. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3963.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine the expression of DNA repair genes in uveal melanoma (UM) and to test whether certain DNA repair genes are differentially expressed between prognostically-good and bad tumors

Methods : A genome-wide gene expression analysis was performed in 64 UMs that were primarily enucleated in the LUMC (Leiden, The Netherlands) between 1999 and 2008. Expression of 117 DNA repair genes was analyzed, and genes with variable expression were selected for further analysis. Expression was compared to histopathological data and survival for genes that showed a significantly differential expression between disomy 3 (D3) and monosomy 3 (M3) tumors. Bonferroni correction was applied for multiple comparisons.
Results were validated by analyzing the expression of these genes in relation to survival in a publicly available set of 110 UMs from the University of Genoa (Italy) and Curie Institute, Paris (France).

Results : We identified 44 DNA repair genes that showed a sufficient level (cut-off standard deviation: ≥ 0.31) of variation in expression. A high expression of PRKDC (p=0.002) and STRA13 (p<0.001) was associated with poor survival in the LUMC set, as were a low expression of XPC (p<0.001), GTF2H4 (p=0.001), BAP1 (p=0.002), SHFM1 (p=0.006), and WDR48 (p<0.001). The associations with survival for PRKDC, XPC, BAP1, and WDR48 (Figure 1) were confirmed in the validation set. The expression values of these genes corresponded positively with the copy number of the respective chromosomes harboring these genes (PRKDC: chromosome 8q; XPC, BAP1 and WDR48: chromosome 3) (all p=0.001). A low expression of XPC and WDR48 was related to a large tumor diameter (p=0.004 and p=0.01, respectively) and a mixed/epithelioid cell type (p=0.03 and p=0.007, respectively).

Conclusions : Certain DNA repair genes are differentially expressed between prognostically-good and bad UMs. An increased understanding of the role of DNA repair genes in UM may result in the identification of new targets of therapy.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

 

Figure 1. Survival curves of DNA repair genes that were significantly associated with survival in both sets. Only the curves for the LUMC cohort are shown. Tumors were divided in two groups by the median expression value.

Figure 1. Survival curves of DNA repair genes that were significantly associated with survival in both sets. Only the curves for the LUMC cohort are shown. Tumors were divided in two groups by the median expression value.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×